Mitral regurgitation assessment of severity: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 56: Line 56:
* If as dense as forward flow, it is severe.
* If as dense as forward flow, it is severe.


===Pulse Wave Doppler(PW)===
===Pulse Wave Doppler (PW)===


* PW in apical-4-chamber view.
* PW in apical-4-chamber view.
* E wave more than 1.2m/s indicates severe MR.
* E wave more than 1.2m/s indicates severe MR.
* Even minor [[mitral stenosis]] or hyperdynamic circulation can increase E wave.
* Even minor [[mitral stenosis]] or hyperdynamic circulation can increase E wave.
* If A-wave dominant, severe MR is virtually ruled out.  
* If A-wave dominant, severe MR is virtually ruled out.


===[[Vena Contracta]]===
===[[Vena Contracta]]===

Revision as of 17:06, 24 July 2013



Intern
Survival
Guide

Mitral Regurgitation Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Mitral Regurgitation from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Stages

History and Symptoms

Physical Examination

Chest X Ray

Electrocardiogram

Echocardiography

Cardiac MRI

Cardiac Catheterization

Treatment

Overview

Acute Mitral Regurgitation Treatment

Chronic Mitral Regurgitation Treatment

Surgery

Follow Up

Case Studies

Case #1

Mitral regurgitation assessment of severity On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mitral regurgitation assessment of severity

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMitral regurgitation assessment of severity

CDC on Mitral regurgitation assessment of severity

Mitral regurgitation assessment of severity in the news

Blogs on Mitral regurgitation assessment of severity

Directions to Hospitals Treating Mitral regurgitation

Risk calculators and risk factors for Mitral regurgitation assessment of severity

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S. [3]; Lakshmi Gopalakrishnan, M.B.B.S. [4]

Overview

The severity of MR can be assessed by both clinical and echocardiographic criteria. Careful history is important to establish an estimate of baseline exercise tolerance of the patient.

Assessment of Severity of Mitral Regurgitation

The degree of severity of mitral regurgitation can be quantified by the percentage of the left ventricular stroke volume that regurgitates into the left atrium (the regurgitant fraction).

The 2006 ACC/AHA guidelines included recommendations for echocardiographic monitoring in asymptomatic patients with chronic MR [1]. Echocardiography is performed to assess the left ventricular ejection fraction and end-systolic dimension.

Determination of the degree of mitral regurgitation
Degree of mitral regurgitation Regurgitant fraction Regurgitant Orifice area
Mild mitral regurgitation< 20 percent
Moderate mitral regurgitation20 - 40 percent
Moderate to severe mitral regurgitation40 - 60 percent
Severe mitral regurgitation> 60 percent> 0.3 cm2


Methods that have been used to assess the regurgitant fraction in mitral regurgitation include:

  • Echocardiography.
  • Cardiac catheterization.
  • Fast CT scan.
  • Cardiac MRI.

The echocardiographic technique to measure the regurgitant fraction is to determine the forward flow through the mitral valve (from the left atrium to the left ventricle) during ventricular diastole, and comparing it with the flow out of the left ventricle through the aortic valve in ventricular systole.

This method assumes that the aortic valve does not suffer from aortic insufficiency. The regurgitant fraction would be described as:

Regurgitant fraction = { (Vmitral - Vaortic) ÷ Vmitral } x 100% where Vmitral and Vaortic are respectively the volumes of blood that flow forward through the mitral valve and aortic valve during a cardiac cycle.

Another way to quantify the degree of mitral regurgitation is to determine the area of the regurgitant flow at the level of the valve. This is known as the regurgitant orifice area, and correlates with the size of the defect in the mitral valve.

One particular echocardiographic technique used to measure the orifice area is measurement of the proximal isovelocity surface area (PISA). The flaw of using PISA to determine the mitral valve regurgitant orifice area is that it measures the flow at one moment in time in the cardiac cycle, which may not reflect the average performance of the regurgitant jet.

Colour Flow Mapping

  • Size of flow recruitment is noted.
  • Jet base width at the valve level.
  • Intra atrial jet area if it is a central jet.
  • Jet direction is usually away from a prolapsing leaflet and behind a restricted leaflet.

Continuous Wave Doppler

  • Shape and density of signal - In severe Mitral regurgitation, the flow is dense and triangular.
  • If as dense as forward flow, it is severe.

Pulse Wave Doppler (PW)

  • PW in apical-4-chamber view.
  • E wave more than 1.2m/s indicates severe MR.
  • Even minor mitral stenosis or hyperdynamic circulation can increase E wave.
  • If A-wave dominant, severe MR is virtually ruled out.

Vena Contracta

  • vena contracta is the narrowest region of regurgitant jet (usually just below the valve in LA).
  • >0.7 cm - severe MR.

Pulmonary Venous Flow

  • Usually forward throughout cycle.
  • Systolic dominant.
  • As MR worsens, there is a blunting of systolic flow.
  • If severe MR - systolic flow reversal.

Regurgitant Volume

  • Mitral regurgitant volume = Mitral inflow volume - LV outflow volume.
Mitral inflow volume = Vti * Cross sectional area of mitral valve.
LV outflow volume = Vti * Cross sectional area at LV outflow.
  • Regurtitant volume - <20% - mild , >50% severe

PISA (Proximal Isovelocity Surface Area)

The radius of Proximal isovelocity surface area or flow convergence zone which is a 3-dimensional surface area proximal to a narrowed orifice at which all the blood velocities are equal, can be used to calculate the severity of mitral regurgitation. The principle is that if the mitral regurgitation is mild, only the blood nearer to the valve orifice accelerates towards the atrium while in severe regurgitation, blood farther away from the valve moves back.

PISA radius

A simple method to determine severity of mitral regurgitation is to measure the PISA radius. Regurgitation is mild if radius is <0.4 cm and severe if >1 cm.

Regurgitant Flow (Instantaneous)

The instantaneous regurgitant flow can be calculated from the PISA radius and can be used to assess the severity of mitral regurgitation.

Regurgitant flow = 2π * r2 * Valiasing

Effective Regurgitant Orifice Area (EROA)

Effective regurgitant orifice area can be calculated using the instantaneous regurgitant flow. The formula can be derived from the following:

Valiasing * 2πr2 = Vmax * EROA

hence:

  • EROA = PISA (2πr2) * Valiasing / Vmax

Mild = 0-20 cm2, moderate = 20 - 40 cm2, severe = >40 cm2

Regurgitant volume can be calculated from this.

  • Regurgitant volume = Effective regurgitant orifice area * Vtime integrale

Diastolic Mitral Regurgitation Secondary to Severe Aortic Stenosis

Diastolic mitral regurgitation due to severe aortic stenosis
Diastolic mitral regurgitation due to severe aortic stenosis
Diastolic mitral regurgitation due to severe aortic stenosis


{{#ev:youtube|wzYVcqVLspw}}

{{#ev:googlevideo|424719160215823743&hl=en}}

{{#ev:googlevideo|-1316686479831791521&hl=en}}

Severity (Summary)

Severity of Mitral Regurgitation
Severity mild severe
Jet area <4 cm2 >8 cm2
Jet width thin >0.6
vena contracta <0.3 >0.7
PISA radius <0.4 >1
Pulmonary venous flow systolic dominant systolic flow reversal
Mitral inflow can be A wave dominant E wave dominant >1.2m/s
Continuous wave doppler soft and parabolic dense and triangular
LV and LA normal size enlarged (in chronic MR)
duration can be short holosystolic
Regurgitant volume <30 ml >60 ml
EROA 0-20 cm2 >40 cm2

References

  1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172.

Template:WH Template:WS